The Bridge program is slated to run until the end of 2027, prompting providers to raise concerns about what will happen if the government does not extend it as people typically regain the weight they lost after stopping a GLP-1
On drug interactions specifically, HumeCare's safety materials note that these medications delay gastric emptying, which can affect how other oral medications are absorbed, and that you should not take two GLP-1 or GLP-1/GIP medications at the same time - HumeCare's Terms require you to disclose any current or recent prescriptions for either compounded or brand-name weight loss medication
Protective effects of incretin against age-related diseases
Glucose tolerance, compound tolerance and insulin tolerance tests Mice were fasted for 5 h before being challenged with an intraperitoneal injection of 1.75 g kg 1 of glucose dissolved in isotonic saline
Once approved, access to the datasets will be granted within 4 weeks
However, weight loss will eventually stabilize again as your body adapts to the new dose